HLA-G Expression in Cancers: Potential Role in Diagnosis, Prognosis and Therapy
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
11
Page:
76-89
Author(s):
Wei-Hua Yan
Pharmacologic Activation of p53 by Small-Molecule MDM2 Antagonists
Journal:
Current Pharmaceutical Design
Volume:
17
Page:
560-568
Author(s):
Hong Shen and Carl G. Maki
Heme Oxygenase-1 in Tumor Biology and Therapy
Journal:
Current Drug Targets
Volume:
11
Page:
1551-1570
Author(s):
Halina Was, Jozef Dulak and Alicja Jozkowicz
Dihydrofolate Reductase Gene Variations in Susceptibility to Disease and Treatment Outcomes
Journal:
Current Genomics
Volume:
11
Page:
578-583
Author(s):
Bahram S. Askari and Maja Krajinovic
Metabolic Functions of Myostatin and GDF11
Journal:
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)
Volume:
10
Page:
217-231
Author(s):
Alexandra C. McPherron
MicroRNA Polymorphisms, MicroRNA Pharmacogenomics and Cancer Susceptibility
Journal:
Current Pharmacogenomics and Personalized Medicine
Volume:
8
Page:
289-305
Author(s):
William Xu, Qi Zhao Wang, Qi Cui and Ruian Xu
Seeking the 5th Base of DNA Using Chromatographic Methods of Analysis
Journal:
Current Organic Chemistry
Volume:
14
Page:
2268-2281
Author(s):
S. Kouidou, L. Kovatsi and A. Ioannou
Transport Mechanisms at the Blood-Cerebrospinal-Fluid Barrier: Role of Megalin (LRP2)
Journal:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Volume:
4
Page:
190-205
Author(s):
Carlos Spuch and Carmen Navarro
Emerging Therapies in Relapsing-Remitting Multiple Sclerosis
Journal:
Reviews on Recent Clinical Trials
Volume:
5
Page:
179-188
Author(s):
James J. Marriott and Paul W. O'Connor
Sex Hormones and their Analogues in Neuroimmune Biology
Journal:
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)
Volume:
10
Page:
142-181
Author(s):
Istvan Berczi, Reino Laatikainen and Juha Pulkkinen